MannKind Corporation, a biopharmaceutical company, announces the results of the experiments of their inhaled insulin product. The company has done an year long experiment. Finally they have come to the conclusion that the product is effective in controlling the blood-glucose levels and didn’t raise concerns about lung function.
MannKind said the results are from one of three major late-stage studies, with the others looking at long-term efficacy and safety. The company said it plans to submit the drug to the FDA by the end of the year or early in 2009.
Other companies like the Eli Lilly, Alkermes, Novo Nordisk are still working on the inhaled insulin.
Thus the product is one step ahead of the Pfizer made product Exubera. The product used to lower blood glucose down but the safety questions had to do with long-term use.
The MannKind product however, has to go a long way before make it to market.
Source: The Wall Street Journal
Filed under Diabetes, Diabetes Drug, Insulin | Tags: blood glucose levels, Exubera, inhaled insulin product, MannKind Corporation, Pfizer | Comment Below
Related?
MannKind Corporation to host live broadcast of clinical trial for diabetes drug December 17th, 2008 For the first time, MannKind Corporation will host a live broadcast to review clinical results from its final two Phase 3 studies of AFRESA(TM). To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507.
Insulin Inhaler Exubera Rejected by National Institute for Health and Clinical Excellence for CostApril 19th, 2006 Insulin that can be inhaled rather than injected has been rejected by NHS advisers on grounds of cost. The inhaled insulin "Exubera" is the first non-injected option for insulin therapy since the discovery of the treatment for diabetes in the 1920s.
Technosphere Insulin Over Other Treatment RegimensMarch 8th, 2006 Diabetes and cancer treatments developer MannKind has initiated patient enrollment in two pivotal 12-month phase III clinical trials of its Technosphere Insulin in patients with type 1 and type 2 diabetes. The main objective of these studies is to evaluate the efficacy of Technosphere Insulin (TI) by assessing changes both in HbA1c levels as well as in blood glucose levels after a standardized meal.
Insulet Corporation, Manufacturer of Orbimed (Device Which Delivers Insulin Wirelessly From PDM) Raises $50 MillionApril 4th, 2006 Insulet Corporation, located in Bedford, Massachusetts, is an innovative, privately held, diabetes management company dedicated to providing superior treatment options and lifelong health benefits to people with diabetes. Insulet Corporation, developer and manufacturer of the OmniPod Insulin Management System, an innovative new product for managing diabetes, has raised $50 million in financing from an investor group that was led by OrbiMed Advisors LLC.
Boca Issues Nationwide Recall of Ultilet Insulin SyringeApril 22nd, 2006 Boca Medical Products, Inc., of Coral Springs, Florida is initiating a recall of 3984 boxes of Ultilet Insulin Syringe 30g 1/2cc product lot number 5GEXI as displayed on the inner case, due to possible bacterial presence. The product is being recalled because of possible bacterial presence of Bacillus Cereus and Staphylococcus Intermedius.
Pfizer Receives FDA Approval for Exubera - First Inhalable Insulin for Controlling Type-1 and Type-2 DiabetesMarch 13th, 2006 People who could benefit from insulin are fearful of injections, so they delayed treatment by 5-10 ten years, placing themselves at risk of serious complications. Exubera (manufactured by Pfizer) can improve blood sugar level with fewer or no painful injections.
Novartis's New Solution For DiabetesMay 11th, 2008 Come spring and the American Chemical Society is ready to reveal identity of their experimental drugs which is ready to be tested on human being. This year the annual event took place at the Morial Convention Center in New Orleans.
ReliOn sterile Insulin Syringes recalled nationwide for mislabelingNovember 7th, 2008 FDA announces the Tyco Healthcare Group LP. has recalled ReliOn sterile Insulin Syringes.
